- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Daily Derm Times: June 4, 2025
Author(s):
Key Takeaways
- Denifanstat demonstrates significant efficacy as a novel oral treatment for moderate to severe acne in a Chinese phase 3 study.
- Emerging therapies for lichen planus address unmet needs, offering innovative solutions and new treatment trends.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Journal Digest: June 4, 2025
This review of the latest dermatologic studies includes insights into clinical manifestations of mpox infection, therapeutic modulation of Demodex density via isotretinoin, and more.
Denifanstat Hits All Targets in Chinese Study
Sagimet Biosciences reveals denifanstat's promising phase 3 results, offering a novel oral treatment for moderate to severe acne with significant efficacy.
Bridging the Gaps in Lichen Planus Treatment: Emerging Therapies and Clinical Realities
In part 2 of this conversation, Adam Friedman, MD, FAAD, discusses new data on lichen planus treatment trends, unmet needs, and the promise of innovative therapies.
Examining the Halfway Mark of 2025 in Dermatology
Discover the latest advancements in dermatology in our June issue, including FDA approvals, innovative treatments, and expert insights shaping patient care today.
Road to RAD: What’s Next in the AD Pipeline?
Jonathan Silverberg, MD, PhD, MPH, shared insights into the rapidly evolving therapeutic landscape for atopic dermatitis.
Time in the Market: What History Tells Us About Investing During Volatile Markets
Market pullbacks tempt investors to time the market, but history shows staying invested beats guessing the highs and lows—time > timing.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
